Michael Yang, ViaCyte CEO

Af­ter years of fail­ure, Vi­a­Cyte shows off first proof-of-con­cept for di­a­betes stem cell trans­plants

Sev­en years af­ter they first tried it, Vi­a­Cyte fi­nal­ly has da­ta show­ing that their stem cell treat­ment for di­a­betes — a po­ten­tial cure — can work in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA